S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Sell every Stock except ONE (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
MarketBeat: Week in Review 8/8 - 8/12
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Climate bill: Could coal communities shift to nuclear?
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Sell every Stock except ONE (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
MarketBeat: Week in Review 8/8 - 8/12
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Climate bill: Could coal communities shift to nuclear?
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Sell every Stock except ONE (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
MarketBeat: Week in Review 8/8 - 8/12
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Climate bill: Could coal communities shift to nuclear?
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
2 Important Retail Stock Battles to Watch
Sell every Stock except ONE (Ad)
Pipeline break spills 45,000 gallons of diesel in Wyoming
Sinema took Wall Street money while killing tax on investors
MarketBeat: Week in Review 8/8 - 8/12
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
Expanded IRS free-file system one step closer in Dems' bill
In Biden's big bill: Climate, health care, deficit reduction
Climate bill: Could coal communities shift to nuclear?
Trading Millionaire Reveals, “2008 Was My Most Profitable Year” (Ad)
NASDAQ:HEPA

Hepion Pharmaceuticals - HEPA Earnings Date, Estimates & Call Transcripts

$0.72
-0.02 (-2.72%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.65
$0.76
50-Day Range
$0.51
$0.75
52-Week Range
$0.49
$1.85
Volume
280,517 shs
Average Volume
185,542 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50
Skip Charts & View Estimated and Actual Earnings Data

HEPA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HEPA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Hepion Pharmaceuticals Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $-0.57 EPS

Hepion Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/15/2020Q3($0.51)($0.69)($0.18)($0.69)
8/12/2020Q2 2020($0.50)($0.58)($0.08)($0.58)
8/12/2020Q2 2020($0.50)($0.58)($0.08)($0.58)
6/29/2020Q1 2020($0.97)($0.97)($0.97)
6/29/2020Q1 2020($0.97)($0.97)($0.97)
11/14/2019Q3 2019($0.64)($0.53)+$0.11($0.53)
11/14/2019Q3 2019($0.64)($0.53)+$0.11($0.53)
8/14/2019Q2 2019($7.48)($7.48)($7.48)
8/14/2019Q2 2019($7.48)($7.48)($7.48)
5/15/2019Q1 2019($7.69)($7.69)($7.69)
5/15/2019Q1 2019($7.69)($7.69)($7.69)
3/14/2019Q4 2018($11.89)($11.89)($11.89)
3/14/2019Q4 2018($11.89)($11.89)($11.89)
11/14/2018Q3 2018($62.94)($62.94)($81.82)
11/14/2018Q3 2018($62.94)($62.94)($81.82)
8/14/2018Q2 2018($26.57)($26.57)($26.57)
8/14/2018Q2 2018($26.57)($26.57)($26.57)
5/15/2018Q1 2018($16.78)($16.78)($16.78)
5/15/2018Q1 2018($16.78)($16.78)($16.78)
4/12/2017Q1 2017($78.32)($44.76)+$33.56($22.39)
4/12/2017Q1 2017($78.32)($44.76)+$33.56($22.39)
2/14/2017Q4 2016($78.32)($61.54)+$16.78($78.32)
2/14/2017Q4 2016($78.32)($61.54)+$16.78($78.32)
11/14/2016Q3 2016($78.32)($72.73)+$5.59($72.73)
11/14/2016Q3 2016($78.32)($72.73)+$5.59($72.73)
9/28/2016Q2 2016($83.92)($89.51)($5.59)($87.27)
9/28/2016Q2 2016($83.92)($89.51)($5.59)($87.27)
5/13/2016Q1 2016($128.67)($78.32)+$50.35($78.32)
5/13/2016Q1 2016($128.67)($78.32)+$50.35($78.32)
2/12/2016Q4 2015($139.86)($111.89)+$27.97($162.24)
2/12/2016Q4 2015($139.86)($111.89)+$27.97($162.24)
11/12/2015Q3 2015($123.08)($123.08)($123.08)
11/12/2015Q3 2015($123.08)($123.08)($123.08)
9/25/2015Q2 2015($324.48)($324.48)($324.48)
9/25/2015Q2 2015($324.48)($324.48)($324.48)
5/14/2015Q1 2015($83.92)($111.89)($27.97)($111.89)
5/14/2015Q1 2015($83.92)($111.89)($27.97)($111.89)












Hepion Pharmaceuticals Earnings - Frequently Asked Questions

How much profit does Hepion Pharmaceuticals generate each year?

Hepion Pharmaceuticals (NASDAQ:HEPA) has a recorded net income of -$32.72 million. HEPA has generated $0.00 earnings per share over the last four quarters.

What is Hepion Pharmaceuticals's EPS forecast for next year?

Hepion Pharmaceuticals's earnings are expected to decrease from ($0.43) per share to ($0.57) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:HEPA) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.